93 related articles for article (PubMed ID: 11742892)
21. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia.
ter Avest E; Sniderman AD; Bredie SJ; Wiegman A; Stalenhoef AF; de Graaf J
Clin Sci (Lond); 2007 Jan; 112(2):131-9. PubMed ID: 17054424
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-alpha is a marker of familial combined hyperlipidemia, independently of metabolic syndrome.
Pauciullo P; Gentile M; Marotta G; Baiano A; Ubaldi S; Jossa F; Iannuzzo G; Faccenda F; Panico S; Rubba P
Metabolism; 2008 Apr; 57(4):563-8. PubMed ID: 18328361
[TBL] [Abstract][Full Text] [Related]
23. The effect of ciprofibrate on flow-mediated dilation and inflammatory markers in patients with combined hyperlipidemia.
Kovács I; Toldy E; Abel T; Tarján J; Császár A
Endothelium; 2005; 12(4):179-83. PubMed ID: 16162440
[TBL] [Abstract][Full Text] [Related]
24. The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate.
Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Cariolou M; Ganotakis ES; Mikhailidis DP; Elisaf MS
J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):211-21. PubMed ID: 17056835
[TBL] [Abstract][Full Text] [Related]
25. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Walldius G; Hamsten A; Hellénius ML; Fisher RM
Eur Heart J; 2007 Nov; 28(21):2637-43. PubMed ID: 17766927
[TBL] [Abstract][Full Text] [Related]
26. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein B and insulin resistance are good markers of carotid atherosclerosis in patients with type 2 diabetes mellitus.
Matsumoto K; Fujita N; Nakamura K; Senoo T; Tominaga T; Ueki Y
Diabetes Res Clin Pract; 2008 Oct; 82(1):93-7. PubMed ID: 18684539
[TBL] [Abstract][Full Text] [Related]
28. Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein B.
Stein EA; Sniderman A; Laskarzewski P
Am J Cardiol; 2005 Nov; 96(9A):36K-43K; discussion 34K-35K. PubMed ID: 16291013
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study.
Sattar N; Williams K; Sniderman AD; D'Agostino R; Haffner SM
Circulation; 2004 Oct; 110(17):2687-93. PubMed ID: 15492304
[TBL] [Abstract][Full Text] [Related]
30. Clinical inquiries. When should we screen children for hyperlipidemia?
Misicko NE; St Anna L; Foliaco W
J Fam Pract; 2006 Aug; 55(8):723-5. PubMed ID: 16882449
[TBL] [Abstract][Full Text] [Related]
31. [Familial combined hyperlipidemia].
Inoue I
Nihon Rinsho; 2007 Jul; 65 Suppl 7():309-20. PubMed ID: 17824049
[No Abstract] [Full Text] [Related]
32. Genetics of familial combined hyperlipidemia.
Naukkarinen J; Ehnholm C; Peltonen L
Curr Opin Lipidol; 2006 Jun; 17(3):285-90. PubMed ID: 16680034
[TBL] [Abstract][Full Text] [Related]
33. Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.
Eurlings PM; van der Kallen CJ; Vermeulen VM; de Bruin TW
Mol Genet Metab; 2003 Nov; 80(3):296-301. PubMed ID: 14680975
[TBL] [Abstract][Full Text] [Related]
34. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
[TBL] [Abstract][Full Text] [Related]
35. Serum alanine aminotransferase is associated with serum adiponectin, C-reactive protein and apolipoprotein B in young healthy men.
Kazumi T; Kawaguchi A; Hirano T; Yoshino G
Horm Metab Res; 2006 Feb; 38(2):119-24. PubMed ID: 16523413
[TBL] [Abstract][Full Text] [Related]
36. Brachial endothelial function in subjects with familial combined hyperlipidemia and its relationships to carotid artery intima-media thickness.
Karásek D; Vaverková H; Halenka M; Budíková M; Novoty D
Int Angiol; 2006 Dec; 25(4):418-26. PubMed ID: 17164751
[TBL] [Abstract][Full Text] [Related]
37. Lipid metabolism.
Lewis GF
Curr Opin Lipidol; 2002 Feb; 13(1):97-9. PubMed ID: 11790968
[No Abstract] [Full Text] [Related]
38. Familial combined hyperlipidaemia: how can genetic disorders be common, complex and comprehensible?
Sniderman A; Bailey SD; Engert JC
Clin Sci (Lond); 2007 Nov; 113(9):365-7. PubMed ID: 17608621
[TBL] [Abstract][Full Text] [Related]
39. Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia.
Allayee H; Castellani LW; Cantor RM; de Bruin TW; Lusis AJ
Circ Res; 2003 Jun; 92(11):1262-7. PubMed ID: 12738753
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein B versus LDL-cholesterol: Association with other risk factors for atherosclerosis.
Vaverkova H; Karasek D; Novotny D; Jackuliakova D; Lukes J; Halenka M; Frohlich J
Clin Biochem; 2009 Aug; 42(12):1246-51. PubMed ID: 19450572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
